| Amy D Noland, MD | |
|
209 Martin Luther King Jr Way, Tacoma, WA 98405-4265 | |
| (253) 596-3300 | |
| (253) 596-3301 |
| Full Name | Amy D Noland |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 17 Years |
| Location | 209 Martin Luther King Jr Way, Tacoma, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285953240 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | N3951 (Texas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kaiser Foundation Health Plan Of Washington | 9032022579 | 1480 |
News Archive
InNexus Biotechnology Inc., a drug development company commercializing the next generation of antibodies based on its groundbreaking Dynamic Cross Linking (DXL™) technology, today announced the Company has entered into a Collaboration Agreement with the National Cancer Institute (NCI) of the U.S. National Institutes of Health (NIH) to research proprietary technologies developed by InNexus.
NanoViricides, Inc. announced today that it has been invited to present its anti-influenza drug development studies at the TechConnect World 2011 Conferences and Expo.
Mothers who are depressed respond differently to their crying babies than do non-depressed moms. In fact, their reaction, according to brain scans at the University of Oregon, is much more muted than the robust brain activity in non-depressed moms.
Researchers in the United States and Austria have demonstrated the potential of a modified influenza virus as a vaccine to protect against viral respiratory pathogens, including the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes coronavirus disease 2019 (COVID-19).
› Verified 9 days ago
| Entity Name | Kaiser Foundation Health Plan Of Washington |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396810701 PECOS PAC ID: 9032022579 Enrollment ID: O20031112000454 |
News Archive
InNexus Biotechnology Inc., a drug development company commercializing the next generation of antibodies based on its groundbreaking Dynamic Cross Linking (DXL™) technology, today announced the Company has entered into a Collaboration Agreement with the National Cancer Institute (NCI) of the U.S. National Institutes of Health (NIH) to research proprietary technologies developed by InNexus.
NanoViricides, Inc. announced today that it has been invited to present its anti-influenza drug development studies at the TechConnect World 2011 Conferences and Expo.
Mothers who are depressed respond differently to their crying babies than do non-depressed moms. In fact, their reaction, according to brain scans at the University of Oregon, is much more muted than the robust brain activity in non-depressed moms.
Researchers in the United States and Austria have demonstrated the potential of a modified influenza virus as a vaccine to protect against viral respiratory pathogens, including the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes coronavirus disease 2019 (COVID-19).
› Verified 9 days ago
| Entity Name | Northwest Emergency Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235172370 PECOS PAC ID: 3476462334 Enrollment ID: O20041214000892 |
News Archive
InNexus Biotechnology Inc., a drug development company commercializing the next generation of antibodies based on its groundbreaking Dynamic Cross Linking (DXL™) technology, today announced the Company has entered into a Collaboration Agreement with the National Cancer Institute (NCI) of the U.S. National Institutes of Health (NIH) to research proprietary technologies developed by InNexus.
NanoViricides, Inc. announced today that it has been invited to present its anti-influenza drug development studies at the TechConnect World 2011 Conferences and Expo.
Mothers who are depressed respond differently to their crying babies than do non-depressed moms. In fact, their reaction, according to brain scans at the University of Oregon, is much more muted than the robust brain activity in non-depressed moms.
Researchers in the United States and Austria have demonstrated the potential of a modified influenza virus as a vaccine to protect against viral respiratory pathogens, including the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes coronavirus disease 2019 (COVID-19).
› Verified 9 days ago
| Entity Name | Northwest Observation Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023539376 PECOS PAC ID: 9032480942 Enrollment ID: O20170810000470 |
News Archive
InNexus Biotechnology Inc., a drug development company commercializing the next generation of antibodies based on its groundbreaking Dynamic Cross Linking (DXL™) technology, today announced the Company has entered into a Collaboration Agreement with the National Cancer Institute (NCI) of the U.S. National Institutes of Health (NIH) to research proprietary technologies developed by InNexus.
NanoViricides, Inc. announced today that it has been invited to present its anti-influenza drug development studies at the TechConnect World 2011 Conferences and Expo.
Mothers who are depressed respond differently to their crying babies than do non-depressed moms. In fact, their reaction, according to brain scans at the University of Oregon, is much more muted than the robust brain activity in non-depressed moms.
Researchers in the United States and Austria have demonstrated the potential of a modified influenza virus as a vaccine to protect against viral respiratory pathogens, including the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes coronavirus disease 2019 (COVID-19).
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Amy D Noland, MD 209 Martin Luther King Jr Way, Tacoma, WA 98405-4265 Ph: (253) 596-3300 | Amy D Noland, MD 209 Martin Luther King Jr Way, Tacoma, WA 98405-4265 Ph: (253) 596-3300 |
News Archive
InNexus Biotechnology Inc., a drug development company commercializing the next generation of antibodies based on its groundbreaking Dynamic Cross Linking (DXL™) technology, today announced the Company has entered into a Collaboration Agreement with the National Cancer Institute (NCI) of the U.S. National Institutes of Health (NIH) to research proprietary technologies developed by InNexus.
NanoViricides, Inc. announced today that it has been invited to present its anti-influenza drug development studies at the TechConnect World 2011 Conferences and Expo.
Mothers who are depressed respond differently to their crying babies than do non-depressed moms. In fact, their reaction, according to brain scans at the University of Oregon, is much more muted than the robust brain activity in non-depressed moms.
Researchers in the United States and Austria have demonstrated the potential of a modified influenza virus as a vaccine to protect against viral respiratory pathogens, including the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes coronavirus disease 2019 (COVID-19).
› Verified 9 days ago
Dr. Justin Cha-cheng Ng, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 315 Martin Luther King Jr Way, Tacoma, WA 98405 Phone: 253-403-2050 | |
Robert F Wachtel, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 315 Martin Luther King Jr Way, Tacoma, WA 98405 Phone: 253-403-1000 | |
Dr. Nathan Kinneer Friedline, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 9040 Jackson Ave, Tacoma, WA 98433 Phone: 850-885-2273 | |
Barbara Sherry Mezger, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 209 Martin Luther King Jr Way, Tacoma, WA 98405 Phone: 253-596-3400 Fax: 253-596-3301 | |
Dr. Peter Stull, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: Madigan Army Medical Center 9040 Jackson Ave, Tacoma, WA 98431 Phone: 253-968-1250 Fax: 253-968-2550 | |
Kevin E Callahan, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 315 Martin Luther King Jr Way, Tacoma, WA 98405 Phone: 253-403-1000 | |
June A Burn, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 14815 Pacific Ave S, Tacoma, WA 98444 Phone: 253-697-8660 |